Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021

NCT02342548 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02342548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
February 25, 2015
Completion date
February 6, 2017
Enrollment
188 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

huntington's disease